Welcome to THC Science

Bringing Science to the Cannabis Conversation!

What is the Difference Between Hemp and Cannabis?

Paclitaxel Medication used for cancer PaclitaxelClinical dataTrade namesTaxol, othersAHFS/Drugs.comMonographLicense data EU EMA: by INN Pregnancycategory US: D (Evidence of risk) Routes ofadministrationIVATC codeL01CD01 (WHO) L01CD03 (WHO) (paclitaxel poliglumex)Legal statusLegal status AU: S4 (Prescription only) CA: ℞-only UK: POM (Prescription only) US: ℞-only Pharmacokinetic dataBioavailability6.5% (by mouth)[1]Protein binding89 to 98%MetabolismLiver (CYP2C8 and CYP3A4)Elimination half-life5.8 hoursExcretionFecal and urinaryIdentifiers IUPAC name (2α,4α,5β,7β,10β,13α)-4,10-Bis(acetyloxy)-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate CAS Number33069-62-4 YPubChem CID36314IUPHAR/BPS2770DrugBankDB01229 YChemSpider10368587 YUNIIP88XT4IS4DKEGGD00491 YChEBICHEBI:45863 YChEMBLChEMBL428647 NPDB ligandTA1… read more »

Research

Paclitaxel Medication used for cancer PaclitaxelClinical dataTrade namesTaxol, othersAHFS/Drugs.comMonographLicense data EU EMA: by INN Pregnancycategory US: D (Evidence of risk) Routes ofadministrationIVATC codeL01CD01 (WHO) L01CD03 (WHO) (paclitaxel poliglumex)Legal statusLegal status AU: S4 (Prescription only) CA: ℞-only UK: POM (Prescription only) US: ℞-only Pharmacokinetic dataBioavailability6.5% (by mouth)[1]Protein binding89 to 98%MetabolismLiver (CYP2C8 and CYP3A4)Elimination half-life5.8 hoursExcretionFecal and urinaryIdentifiers IUPAC name (2α,4α,5β,7β,10β,13α)-4,10-Bis(acetyloxy)-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate CAS Number33069-62-4 YPubChem CID36314IUPHAR/BPS2770DrugBankDB01229 YChemSpider10368587 YUNIIP88XT4IS4DKEGGD00491 YChEBICHEBI:45863 YChEMBLChEMBL428647 NPDB ligandTA1… read more »

THC Science Mission to Share Cannabis Science with the World

Paclitaxel Medication used for cancer PaclitaxelClinical dataTrade namesTaxol, othersAHFS/Drugs.comMonographLicense data EU EMA: by INN Pregnancycategory US: D (Evidence of risk) Routes ofadministrationIVATC codeL01CD01 (WHO) L01CD03 (WHO) (paclitaxel poliglumex)Legal statusLegal status AU: S4 (Prescription only) CA: ℞-only UK: POM (Prescription only) US: ℞-only Pharmacokinetic dataBioavailability6.5% (by mouth)[1]Protein binding89 to 98%MetabolismLiver (CYP2C8 and CYP3A4)Elimination half-life5.8 hoursExcretionFecal and urinaryIdentifiers IUPAC name (2α,4α,5β,7β,10β,13α)-4,10-Bis(acetyloxy)-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate CAS Number33069-62-4 YPubChem CID36314IUPHAR/BPS2770DrugBankDB01229 YChemSpider10368587 YUNIIP88XT4IS4DKEGGD00491 YChEBICHEBI:45863 YChEMBLChEMBL428647 NPDB ligandTA1… read more »

Sidebar